Big Pharma is pouring money into tech-devised treatments, but the verdict is out on whether they’ll actually work.

The FDA has introduced models intended to accelerate rare disease drug development, but recent reversals of guidance from the ...

A proof-of-concept study has created a blueprint for producing prostate cancer treatment more efficiently. Researchers at the ...

Provides End-To-End Services for Preclinical & Clinical Projects with Extensive Experience in Decoding Biologics Production ...

Piramal Pharma Solutions has entered into an agreement with Botanix SB Inc., a subsidiary of Botanix Pharmaceuticals Limited, ...

Eli Lilly's work in diabetes and weight loss is doing most of the heavy lifting right now. The company's financial results ...

Bingchuan Wei of Genentech explains how HIC-MS integrates separation and mass detection to resolve and quantify individual ...

Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel ...

SAN DIEGO, CA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- Which CRO Is Good at Protein Degradation? Key ...

Researchers at The University of Texas Medical Branch (UTMB) have identified how a key enzyme called ATR protects DNA from ...

NASA has enabled scientists to study the impact of microgravity on drug development for decades, beginning with the Space ...

Dr. Richard Graham explains how FDA’s new program allows for the usage of real-time data during clinical trials. In April, ...